Roberta Baschi
Liége, 4000, Belgium
NCT Number: NCT02125422
Transcranial direct current stimulation is a tool to modulate cortical excitability.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Phase 1
Liége, 4000, Belgium
Anodal transcranial direct currenti stimulation over visual cortex is able to decrease the thermo-nociceptive sensibility and thermonociceptive potentials, whilst cathodal transcranial direct current stimulation has the opposite effect, it decreases VEP amplitude and habituation. This neuromodulation technique is probably a tool in the prevention in episodic and chronic migraine.
The aim of the study is to study short and long term effect of tDCS over pain treshold, contact heat evoked potentials, blink reflex and visual evoked potentials in healthy volunteers.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Cefaly tDCS (transcranial direct current stimulation) is able to modify cortical excitability, in particular anodal tDCS increases it. The side effects of tDCS are minor, especially sensations of itching and scalp paresthesias.
Time frame: up to 1 month
Modifications in neurophysiological test after direct current stimulation
Time frame: up to 1 month
Evaluation of changes in latency, amplitude, slope and habituation
Time frame: up to 1 month
Evaluation of changes in latency, amplitude, slope and habituation
Time frame: up to 1 month
Evaluation of changes in latency, amplitude, slope and habituation
Time frame: up to 1 month
Evaluation of changes in thresholds
University of Liege
Other
Acronym: tDCSHV
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05447078
Healthy Volunteers, Infections
Jackson, Mississippi, United States
View Trial DetailsNCT07513532
Healthy Volunteers
Seattle, Washington, United States
View Trial DetailsNCT07090655
Healthy Volunteers
Brisbane, Australia
View Trial DetailsNCT01915212
Communicable Diseases, DNA Virus Infections
Bethesda, Maryland, United States
View Trial Details